News
Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?
- Author:
- Richard Mark Kirkner
Experts in rheumatology, dermatology, and gastroenterology assess the potential of colchicine 0.5 mg to treat residual risk for atherosclerotic...
News
Ticagrelor, DAPT equal in preventing repeat revascularization
- Author:
- Richard Mark Kirkner
After percutaneous coronary intervention, ticagrelor alone or with aspirin are equally effective in preventing repeat revascularization at 1 year...
News
Real-world data validate ESC risk model in NSTE-ACS
- Author:
- Richard Mark Kirkner
A real-world study has potentially validated a risk model put forward by the ESC for management of acute coronary syndromes without persistent ST-...
News
Distal radial access doesn’t harm hand function at 1 year
- Author:
- Richard Mark Kirkner
A head-to-head comparison of distal vs. proximal radial artery access for coronary interventions found no difference in hand function a year later...
News
Anticipating FDA action, SCAI drafts guidance for adoption of renal denervation
- Author:
- Richard Mark Kirkner
“Through the open comment process, we are hoping to gain broad perspective from stakeholders, including clinicians, hospitals, payers,...
News
Marijuana linked to higher PAD risk
- Author:
- Richard Mark Kirkner
A large study found marijuana users had almost four times the risk of peripheral artery disease, but no higher risk of death or coronary...
News
Colchicine’s 2010 price spike had major impact on gout care
- Author:
- Richard Mark Kirkner
Colchicine prescriptions dropped sharply and patient visits for gout-related symptoms increased significantly after a 2010 U.S. Food and Drug...
News
Study of hospitalizations in Canada quantifies benefit of COVID-19 vaccine to reduce death, ICU admissions
- Author:
- Richard Mark Kirkner
Unvaccinated patients were found to be up to 15 times more likely to die from COVID-19 than fully vaccinated patients.
News
A call to revamp revascularization trial endpoints
- Author:
- Richard Mark Kirkner
Coronary revascularization trials should focus more on quality of life than traditional composite outcomes, two trial investigators say.
News
LAA closure outcomes improve with CCTA: Swiss-Apero subanalysis
- Author:
- Richard Mark Kirkner
A trial of left atrial appendage closure reported better outcomes with preprocedure CT than transesophageal echocardiography alone.
News
Red-cell donor’s sex does not affect transfusion survival
- Author:
- Richard Mark Kirkner
New study showed that the sex of a red blood cell donor has no bearing on the survival of the transfusion recipient.
News
New update on left atrial appendage closure recommendations
- Author:
- Richard Mark Kirkner
A new consensus statement on transcatheter left atrial appendage closure tightens standards for patient selection as well as operator experience...
News
Disparities in statin use persist in high-risk Americans
- Author:
- Richard Mark Kirkner
National database analysis finds disparities in primary-prevention statin use persist despite 10-year atherosclerotic cardiovascular disease risk...
News
From PERT to AI, high-risk PE care evolves
- Author:
- Richard Mark Kirkner
Pulmonary embolism response teams have been in the vanguard of care strategies for high-risk PE cases.
News
Biomarkers linked to elevated T2D MACE risk in DECLARE-TIMI 58
- Author:
- Richard Mark Kirkner
A secondary DECLARE-TIMI 58 trial analysis linked two biomarkers to higher cardiovascular risks in diabetes and found a strong benefit of...